New York, NY (PRWEB) June 12, 2014
As vaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) continue to move forward against Johnson & Johnson’s Ethicon Inc. unit in courts around the country, Bernstein Liebhard LLP notes that four women from Washington have asked the state’s Attorney General to investigate Johnson & Johnson’s pelvic mesh business. According to a report published by the Voice of the Valley on June 9, 2014, the women who made the request all claim to have suffered serious transvaginal mesh complications due to the companies’ products, and have asked the Washington State Office of Attorney General to, “pursue this matter to recoup the state taxpayer dollars Medicaid and other public health systems have been and will be forced to spend to treat women who have been injured.”
“We are representing numerous plaintiffs in vaginal mesh lawsuits filed against Ethicon and Johnson & Johnson, and continue to hear from women who allegedly suffered horrific injuries due to the companies’ devices. Our Firm is monitoring this matter very closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate legal claims on behalf of women who suffered serious transvaginal mesh complications, allegedly due to products marketed by Ethicon and other manufacturers.
Transvaginal Mesh Lawsuits
Transvaginal mesh devices are used in the surgical repair of stress urinary incontinence and pelvic organ prolapse. The U.S. Food & Drug Administration (FDA) has been reviewing the safety of transvaginal mesh since October 2008, when it first alerted the public to the serious risk of transvaginal mesh complications associated with these products. In April, the agency proposed new regulations that, if finalized, would reclassify mesh used to treat pelvic organ prolapse as high-risk medical devices, and subject the products to greater regulatory scrutiny.
Court records indicate that more than 18,000 vaginal mesh lawsuits have been filed against Ethicon and Johnson & Johnson in a multidistrict litigation now underway in U.S. District Court, Southern District of West Virginia. All of the lawsuits accuse the companies of failing to provide adequate warnings regarding the risks associated with their pelvic mesh products. Plaintiffs also claim that the products were defectively designed and brought to market without adequate testing. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for the federal Ethicon litigation. (MDL No. 2327))
According to court documents, Ethicon is just one of several defendants involved in pelvic mesh litigations in the Southern District of West Virginia, where more than 55,000 vaginal mesh lawsuits have been filed. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who allegedly suffered serious transvaginal mesh complications may be able to pursue their own vaginal mesh lawsuit against the manufacturer of their device. To learn more about this growing litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP